Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Unicycive Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Meredith S. Manning, Director (Form 8-K filed 2026-09-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vivo Opportunity Fund Holdings, L.P. (filed 2026-08-14).
Who is behind it
Unicycive Therapeutics, Inc.: incorporated in Delaware; business address in Mountain View, California; industry Pharmaceutical Preparations (Form D, 2026-09-29).
Officers and directors, each with the role and the filing that names them:
- Shalabh Gupta: Executive Officer, Director (Form D, 2024-03-20)
- John Townsend: Executive Officer (Form D, 2024-03-20)
- John Ryan: Director (Form D, 2024-03-20)
- Sandeep Laumas: Director (Form D, 2024-03-20)
- Sara Kenkare-Mitra: Director (Form D, 2024-03-20)
- Gaurav Aggarwal: Director (Form D, 2024-03-20)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Vivo Opportunity Fund Holdings, L.P. | 9.99% |
| Schedule 13G/A, 2026-08-14 | Nantahala Capital Management, LLC | 9.99% |
| Schedule 13G, 2026-07-30 | Blackrock, Inc. | 5.3% |
| Schedule 13G/A, 2026-07-08 | Millennium Management LLC | 1% |
| Schedule 13G/A, 2026-05-15 | Ra Capital Management, L.P. | 9.9% |
| Schedule 13G/A, 2026-02-17 | Ra Capital Management, L.P. | 9.9% |
| Schedule 13G/A, 2026-02-13 | Nantahala Capital Management, LLC | 9.99% |
| Schedule 13G/A, 2026-02-10 | Octagon Capital Advisors LP | 4.7% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-29 | Meredith S. Manning | Director | appointed | 2026-10-01 |
| Form 8-K, 2026-04-06 | Gaurav Aggarwal | Director | departed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-03-20 | $50M | $50M |
| Form D, 2023-03-13 | $30.19M | $30.19M |
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/unicycive-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2024-03-20 · Form 8-K, 2026-09-29 · Form 8-K, 2026-04-06
Who owns Unicycive Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/unicycive-therapeutics